On Mar. 26, 2020, Novartis and a consortium of life sciences companies announced a collaboration to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19 in response to the pandemic. Companies participating include:
BD, Boehringer Ingelheim, bioMerieux, Eisai, Eli Lilly, Gilead, GSK, J&J, Merck (MSD), Merck (Merck KGaA), Novartis, Pfizer and Sanofi.